209 related articles for article (PubMed ID: 34118869)
1. Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma.
Lee HA; Goh HG; Lee YS; Jung YK; Kim JH; Yim HJ; Lee MG; An H; Jeen YT; Yeon JE; Byun KS; Seo YS
BMC Gastroenterol; 2021 Jun; 21(1):258. PubMed ID: 34118869
[TBL] [Abstract][Full Text] [Related]
2. Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatments.
Lee IC; Huang YH; Chau GY; Huo TI; Su CW; Wu JC; Lin HC
Int J Cancer; 2013 Dec; 133(12):2895-902. PubMed ID: 23749461
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes of phenotype and function of natural killer cells in peripheral blood before and after thermal ablation of hepatitis B associated hepatocellular carcinoma and their correlation with tumor recurrence.
Wang HY; Cui XW; Zhang YH; Chen Y; Lu NN; Bai L; Duan ZP
BMC Cancer; 2023 May; 23(1):486. PubMed ID: 37254046
[TBL] [Abstract][Full Text] [Related]
4. Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
Yang SY; Wang CC; Chen KD; Liu YW; Lin CC; Chuang CH; Tsai YC; Yao CC; Yen YH; Hsiao CC; Hu TH; Tsai MC
BMC Cancer; 2021 Jan; 21(1):70. PubMed ID: 33446127
[TBL] [Abstract][Full Text] [Related]
5. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
Kuo MJ; Mo LR; Chen CL
BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and peripheral immunity analysis of allogeneic natural killer cells therapy in patients with hepatocellular carcinoma].
Xie YB; Zhang JY; DU ML; Meng FP; Fu JL; Liu LM; Wang SS; Qu R; Lian F; Qiao F; Chen YL; Gao YY; Xu RN; Shi M; Wang FS
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 51(3):591-595. PubMed ID: 31209436
[TBL] [Abstract][Full Text] [Related]
8. Quantitative effect of natural killer-cell licensing on hepatocellular carcinoma recurrence after curative hepatectomy.
Tanimine N; Tanaka Y; Kobayashi T; Tashiro H; Miki D; Imamura M; Aikata H; Tanaka J; Chayama K; Ohdan H
Cancer Immunol Res; 2014 Dec; 2(12):1142-7. PubMed ID: 25135909
[TBL] [Abstract][Full Text] [Related]
9. Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification.
Sun X; Li L; Lyu N; Mu L; Lai J; Zhao M
Cancer Imaging; 2020 Jul; 20(1):42. PubMed ID: 32611383
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma.
Lu SD; Wang YY; Peng NF; Peng YC; Zhong JH; Qin HG; Xiang BD; You XM; Ma L; Li LQ
Medicine (Baltimore); 2016 Feb; 95(5):e2722. PubMed ID: 26844516
[TBL] [Abstract][Full Text] [Related]
11. Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy.
Nishibatake Kinoshita M; Minami T; Tateishi R; Wake T; Nakagomi R; Fujiwara N; Sato M; Uchino K; Enooku K; Nakagawa H; Asaoka Y; Shiina S; Koike K
J Hepatol; 2019 Jan; 70(1):78-86. PubMed ID: 30336183
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
Xu XF; Xing H; Han J; Li ZL; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Li C; Wu MC; Shen F; Yang T
JAMA Surg; 2019 Mar; 154(3):209-217. PubMed ID: 30422241
[TBL] [Abstract][Full Text] [Related]
13. Adoptive Transfer of Autologous Invariant Natural Killer T Cells as Immunotherapy for Advanced Hepatocellular Carcinoma: A Phase I Clinical Trial.
Gao Y; Guo J; Bao X; Xiong F; Ma Y; Tan B; Yu L; Zhao Y; Lu J
Oncologist; 2021 Nov; 26(11):e1919-e1930. PubMed ID: 34255901
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
Gastroenterology; 2015 Jun; 148(7):1383-91.e6. PubMed ID: 25747273
[TBL] [Abstract][Full Text] [Related]
15. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
[TBL] [Abstract][Full Text] [Related]
16. Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation.
Lee TY; Lin JT; Zeng YS; Chen YJ; Wu MS; Wu CY
Hepatology; 2016 May; 63(5):1517-27. PubMed ID: 26426978
[TBL] [Abstract][Full Text] [Related]
17. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
[No Abstract] [Full Text] [Related]
18. Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection.
Jeon MY; Kim HS; Lim TS; Han DH; Kim BK; Park JY; Kim DY; Ahn SH; Choi GH; Choi JS; Han KH; Kim SU
PLoS One; 2019; 14(4):e0214613. PubMed ID: 30947275
[TBL] [Abstract][Full Text] [Related]
19. Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation: Risk Factors and Clinical Significance.
Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Gwak GY; Paik YH; Lim HY; Kim MJ
Radiology; 2015 Jul; 276(1):274-85. PubMed ID: 25734550
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy.
Zou H; Zhu CZ; Wang C; Wang ZS; Ma X; Han B; Wu LQ
Am J Med Sci; 2017 Sep; 354(3):262-267. PubMed ID: 28918833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
